Clinical Trial

Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)

Study acronym: Heartlogic ISR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this trial is to determine if the addition of the Heart Logic diagnostic alerts to standard of care therapies will lessen hospitalizations and improve quality of life in patients with heart failure.
Trial Details
NCT Number NCT07412626
Lead Sponsor Robert Pickett
Collaborators: Boston Scientific Corporation, Ascension Health
Conditions Congestive Heart Failure Chronic, Low Ejection Fraction
Enrollment 135 participants
Start Date 2026-04-01
Primary Completion 2027-12 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-17